Skip to content

Expressive writing, anxiety, depression and quality of life in women with Human Papillomavirus infection

The effect of expressive writing on anxiety, depression and quality of life in women with Human Papillomavirus Infection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20090810002324N22
Enrollment
144
Registered
2025-08-10
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Papillomavirus Infection. Other specified predominantly sexually transmitted diseases

Interventions

Intervention 1: Intervention group: The intervention group will practice the expressive writing technique once a week for four consecutive weeks, dedicating 30 minutes each session. Writing should be

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Age Between 18 and 45 years old Iranian Nationality Ability to read and write Definite diagnosis of Human Papilloma virus (HPV), at least 3 months prior (confirmed by HPV test or diagnosis of genital warts ), documented in the patient's file.

Exclusion criteria

Exclusion criteria: Presence of malignant diseases Concurrent sexually transmitted infections Presence of Cervical Intraepithelial Neoplasia Grade 3 (CIN3) Pregnancy Breastfeeding Presence of known mental disorders (based on self-report of the participant) Consumption of alcohol and drugs Contact with other individuals with HPV infection attending the clinic or membership in shared online groups Occurrence of a stressful event at least 3 months prior

Design outcomes

Primary

MeasureTime frame
The mean score and severity of depression. Timepoint: before the intervention and Immediately after the completion of the intervention. Method of measurement: The Beck Depression Inventory II(BDI-II).;The mean score and severity of anxiety. Timepoint: Before the intervention and Immediately after the completion of the intervention. Method of measurement: The Beck Anxiety Inventory (BAI).;The mean score of quality of life. Timepoint: before the intervention and Immediately after the completion of the intervention. Method of measurement: The World Health Organization Quality of Life Brief Version (WHOQOL-BREF).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Keshavarz

Iran University of Medical Sciences

MKmarkesh@gmail.com+98 21 4365 1139

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026